AU2002338898B2 - Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as gaba a receptor modulators - Google Patents

Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as gaba a receptor modulators Download PDF

Info

Publication number
AU2002338898B2
AU2002338898B2 AU2002338898A AU2002338898A AU2002338898B2 AU 2002338898 B2 AU2002338898 B2 AU 2002338898B2 AU 2002338898 A AU2002338898 A AU 2002338898A AU 2002338898 A AU2002338898 A AU 2002338898A AU 2002338898 B2 AU2002338898 B2 AU 2002338898B2
Authority
AU
Australia
Prior art keywords
compound
formula
ethyl ester
pyrimido
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002338898A
Other languages
English (en)
Other versions
AU2002338898B8 (en
AU2002338898A1 (en
Inventor
Raffaello Masciadri
Andrew William Thomas
Juergen Wichmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2002338898B8 publication Critical patent/AU2002338898B8/en
Publication of AU2002338898A1 publication Critical patent/AU2002338898A1/en
Application granted granted Critical
Publication of AU2002338898B2 publication Critical patent/AU2002338898B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2002338898A 2001-05-18 2002-05-08 Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as gaba a receptor modulators Ceased AU2002338898B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01112222.3 2001-05-18
EP01112222 2001-05-18
PCT/EP2002/005121 WO2002094834A1 (en) 2001-05-18 2002-05-08 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators

Publications (3)

Publication Number Publication Date
AU2002338898B8 AU2002338898B8 (en) 2002-12-03
AU2002338898A1 AU2002338898A1 (en) 2003-05-08
AU2002338898B2 true AU2002338898B2 (en) 2007-03-15

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002338898A Ceased AU2002338898B2 (en) 2001-05-18 2002-05-08 Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as gaba a receptor modulators

Country Status (37)

Country Link
US (1) US6686352B2 (https=)
EP (1) EP1399448B1 (https=)
JP (1) JP4068466B2 (https=)
KR (1) KR100533406B1 (https=)
CN (1) CN1230436C (https=)
AR (1) AR033753A1 (https=)
AT (1) ATE283857T1 (https=)
AU (1) AU2002338898B2 (https=)
BG (1) BG108369A (https=)
BR (1) BR0209859A (https=)
CA (1) CA2446903C (https=)
CZ (1) CZ20033355A3 (https=)
DE (1) DE60202147T2 (https=)
DK (1) DK1399448T3 (https=)
EC (1) ECSP034851A (https=)
ES (1) ES2232778T3 (https=)
GT (1) GT200200087A (https=)
HR (1) HRP20030890A2 (https=)
HU (1) HUP0400743A3 (https=)
IL (2) IL158572A0 (https=)
JO (1) JO2297B1 (https=)
MA (1) MA27024A1 (https=)
MX (1) MXPA03010529A (https=)
MY (1) MY127570A (https=)
NO (1) NO20035104L (https=)
NZ (1) NZ529097A (https=)
PA (1) PA8545201A1 (https=)
PE (1) PE20030041A1 (https=)
PL (1) PL366846A1 (https=)
PT (1) PT1399448E (https=)
RU (1) RU2287531C2 (https=)
SI (1) SI1399448T1 (https=)
SK (1) SK15252003A3 (https=)
TW (1) TWI251489B (https=)
WO (1) WO2002094834A1 (https=)
YU (1) YU90003A (https=)
ZA (1) ZA200308544B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2540987T3 (es) 2004-05-14 2015-07-15 Millennium Pharmaceuticals, Inc. Métodos para preparar inhibidores de la aurora cinasa
AU2005294575B2 (en) * 2004-10-04 2011-11-24 Millennium Pharmaceuticals, Inc. Lactam compounds useful as protein kinase inhibitors
ES2399439T3 (es) * 2004-10-20 2013-04-01 F. Hoffmann-La Roche Ag Derivados de imidazo-benzodiazepina
AU2005299031B2 (en) * 2004-10-20 2011-11-10 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
KR101009860B1 (ko) * 2005-10-11 2011-01-19 에프. 호프만-라 로슈 아게 이미다조 벤조다이아제핀 유도체
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
WO2009078999A1 (en) 2007-12-17 2009-06-25 Janssen Pharmaceutica N.V. Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
US7998952B2 (en) 2008-12-05 2011-08-16 Millennium Pharmaceuticals, Inc. Thiolactams and uses thereof
RU2535032C2 (ru) 2008-12-22 2014-12-10 Милленниум Фармасьютикалз, Инк. Сочетание ингибиторов аврора киназы и анти-cd 20 антител
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
CA2788774A1 (en) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
WO2014153509A1 (en) 2013-03-22 2014-09-25 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
EP3083569B1 (en) 2013-12-20 2022-01-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
JP6987384B2 (ja) 2015-06-19 2021-12-22 エージンバイオ, インコーポレイテッド ベンゾジアゼピン誘導体、組成物、および認知障害を処置するための方法
JP2018524292A (ja) 2015-07-21 2018-08-30 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. オーロラキナーゼインヒビターと化学療法剤の投与
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11414425B2 (en) 2018-06-19 2022-08-16 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
TW201311B (https=) 1991-06-17 1993-03-01 Hoffmann La Roche
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
FR2728902B1 (fr) * 1994-12-29 1997-01-31 Synthelabo Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
WO1999043682A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation 2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives, their preparation and their use as (ant-)agonists for gaba (a) brain receptors
US6177569B1 (en) * 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
CN1390217A (zh) 1999-11-12 2003-01-08 神经原公司 二环和三环杂芳族化合物
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
KR100533406B1 (ko) 2005-12-02
PE20030041A1 (es) 2003-02-07
WO2002094834A1 (en) 2002-11-28
ZA200308544B (en) 2005-01-31
EP1399448A1 (en) 2004-03-24
YU90003A (sh) 2006-08-17
HRP20030890A2 (en) 2005-08-31
IL158572A (en) 2010-02-17
AU2002338898B8 (en) 2002-12-03
NO20035104D0 (no) 2003-11-17
SK15252003A3 (sk) 2004-08-03
JO2297B1 (en) 2005-09-12
US20030055042A1 (en) 2003-03-20
IL158572A0 (en) 2004-05-12
DE60202147D1 (de) 2005-01-05
MY127570A (en) 2006-12-29
JP2004531563A (ja) 2004-10-14
ECSP034851A (es) 2003-12-24
SI1399448T1 (en) 2005-02-28
HUP0400743A3 (en) 2007-09-28
CA2446903A1 (en) 2002-11-28
BG108369A (bg) 2005-01-31
PA8545201A1 (es) 2003-02-28
CN1230436C (zh) 2005-12-07
US6686352B2 (en) 2004-02-03
MA27024A1 (fr) 2004-12-20
PT1399448E (pt) 2005-03-31
MXPA03010529A (es) 2004-03-02
NZ529097A (en) 2005-04-29
TWI251489B (en) 2006-03-21
HUP0400743A2 (hu) 2004-07-28
CN1509289A (zh) 2004-06-30
RU2287531C2 (ru) 2006-11-20
GT200200087A (es) 2003-06-19
ES2232778T3 (es) 2005-06-01
DK1399448T3 (da) 2005-04-11
JP4068466B2 (ja) 2008-03-26
DE60202147T2 (de) 2005-12-01
CA2446903C (en) 2008-12-30
EP1399448B1 (en) 2004-12-01
NO20035104L (no) 2003-11-17
KR20040002975A (ko) 2004-01-07
AR033753A1 (es) 2004-01-07
RU2003136078A (ru) 2005-05-27
BR0209859A (pt) 2004-06-15
ATE283857T1 (de) 2004-12-15
CZ20033355A3 (en) 2004-07-14
HK1066544A1 (en) 2005-03-24
PL366846A1 (en) 2005-02-07

Similar Documents

Publication Publication Date Title
AU2002338898B8 (en) Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as GABA A receptor modulators
AU2002338898A1 (en) Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as GABA A receptor modulators
AU2002217007B2 (en) Benzodiazepine derivatives as GABA A receptor modulators
RU2139873C1 (ru) Имидазодиазепины, способ их получения и лекарственное средство
AU2002217007A1 (en) Benzodiazepine derivatives as GABA A receptor modulators
JPH078869B2 (ja) イミダゾジアゼピン誘導体類
MXPA04009332A (es) Agentes ansioliticos con efectos sedantes y ataxicos.
NO153430B (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme 2-fenyl eller -pyridyl-pyrazolo(4,3-c)kinolin-3(1 og 5h)-on forbindelser.
EP1807432A1 (en) Halogen substituted benzodiazepine derivatives

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 21, NO 11, PAGE(S) 1276 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME F.HOFFMAN-LA ROCHE AG, APPLICATION NO. 2002338898, UNDER INID (71), CORRECT THE APPLICANT NAME TO READ F.HOFFMANN-LA ROCHE AG

FGA Letters patent sealed or granted (standard patent)
TH Corrigenda

Free format text: IN VOL 21, NO 11, PAGE(S) 1276 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME F.HOFFMANN-LA ROCHE AG, APPLICATION NO. 2002338898, UNDER INID (71), CORRECT THE APPLICANT NAME TO READ F. HOFFMANN-LA ROCHE AG AND UNDER INID (54), CORRECT THE INVENTION TITLE TO READ IMIDAZO [1,5-A] PYRIMIDO [5,4-D] BENZAZEPINE DERIVATIVES AS GABA A RECEPTOR MODULATORS

MK14 Patent ceased section 143(a) (annual fees not paid) or expired